Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors

NCT06398782 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT06398782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06398782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 1999
Completion date
December 31, 2018
Enrollment
1,500 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

body composition, cancer survivor, morality